RxDoctor Payments Data

David Chang, DMD

Oral and Maxillofacial Surgery · Boston, MANPI 1083879829

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $39,114 of the $41,935 with a category attached, or 93.3%. Hiossen, Inc. accounts for 93.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $13,176 and has fallen 97.8% since, to $288 in 2025. Among oral and maxillofacial surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,935in general payments, 2019–2025

Across 56 payments — averaging $748.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hiossen, Inc.$39K
  • Stryker$1K
  • Straumann USA LLC$391
  • Axogen$345
  • Integra Lifesciences Corporation$308
  • Nobel Biocare USA$162
  • plus $320 from 6 others

What the payments were for

  • Speaking & faculty fees$39,11493%
  • Food & beverage$2,4956%
  • Education$3251%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,935 in reported general payments places this provider in the 95th percentile of 247 oral and maxillofacial surgery providers in Massachusetts.

See all oral and maxillofacial surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$14,358
Medicare patients
52
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl14$141
Amoxicillin37$93
Acetaminophen-CodeineAcetaminophen With Codeine15$42

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →